Literature DB >> 19277606

Identification of a novel UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) from Vibrio fischeri that confers high fosfomycin resistance in Escherichia coli.

Sanath Kumar1, Ammini Parvathi, Ricardo L Hernandez, Kathleen M Cadle, Manuel F Varela.   

Abstract

MurA [UDP-N-acetylglucosamine (UDP-NAG) enolpyruvyl transferase] is a key enzyme involved in bacterial cell wall peptidoglycan synthesis and a target for the antimicrobial agent fosfomycin, a structural analog of the MurA substrate phosphoenol pyruvate. In this study, we identified, cloned and sequenced a novel murA gene from an environmental isolate of Vibrio fischeri that is naturally resistant to fosfomycin. The fosfomycin resistance gene was isolated from a genomic DNA library of V. fischeri. An antimicrobial agent hypersensitive strain of Escherichia coli harboring murA from V. fischeri exhibited a high fosfomycin resistance phenotype, with minimum inhibitory concentration of 3,000 microg/ml. The cloned murA gene was 1,269 bp long encoding a 422 amino acid polypeptide with an estimated pI of 5.0. The deduced amino acid sequence of the putative protein was identified as UDP-NAG enolpyruvyl transferase by homology comparison. The MurA protein with an estimated molecular weight of 44.7 kDa was expressed in E. coli and purified by affinity chromatography. MurA of V. fischeri will be a useful target to identify potential inhibitors of fosfomycin resistance in pharmacological studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19277606      PMCID: PMC2673340          DOI: 10.1007/s00203-009-0468-9

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  23 in total

1.  VmrA, a member of a novel class of Na(+)-coupled multidrug efflux pumps from Vibrio parahaemolyticus.

Authors:  Jing Chen; Yuji Morita; M Nazmul Huda; Teruo Kuroda; Tohru Mizushima; Tomofusa Tsuchiya
Journal:  J Bacteriol       Date:  2002-01       Impact factor: 3.490

2.  Purification of a glutathione S-transferase that mediates fosfomycin resistance in bacteria.

Authors:  P Arca; C Hardisson; J E Suárez
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

3.  FosB, a cysteine-dependent fosfomycin resistance protein under the control of sigma(W), an extracytoplasmic-function sigma factor in Bacillus subtilis.

Authors:  M Cao; B A Bernat; Z Wang; R N Armstrong; J D Helmann
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

4.  Charactertization of spontaneous fosfomycin (phosphonomycin)-resistant cells of Escherichia coli B in vitro.

Authors:  T Tsuruoka; Y Yamada
Journal:  J Antibiot (Tokyo)       Date:  1975-11       Impact factor: 2.649

5.  Alteration of a single amino acid residue reverses fosfomycin resistance of recombinant MurA from Mycobacterium tuberculosis.

Authors:  Koen A L De Smet; Karen E Kempsell; Alex Gallagher; Ken Duncan; Douglas B Young
Journal:  Microbiology (Reading)       Date:  1999-11       Impact factor: 2.777

6.  Mechanistic diversity of fosfomycin resistance in pathogenic microorganisms.

Authors:  Kerry L Fillgrove; Svetlana Pakhomova; Marcia E Newcomer; Richard N Armstrong
Journal:  J Am Chem Soc       Date:  2003-12-24       Impact factor: 15.419

Review 7.  Fosfomycin: use beyond urinary tract and gastrointestinal infections.

Authors:  Matthew E Falagas; Konstantina P Giannopoulou; George N Kokolakis; Petros I Rafailidis
Journal:  Clin Infect Dis       Date:  2008-04-01       Impact factor: 9.079

8.  In vitro and in vivo functional activity of Chlamydia MurA, a UDP-N-acetylglucosamine enolpyruvyl transferase involved in peptidoglycan synthesis and fosfomycin resistance.

Authors:  Andrea J McCoy; Robin C Sandlin; Anthony T Maurelli
Journal:  J Bacteriol       Date:  2003-02       Impact factor: 3.490

9.  Role of sulA and sulB in filamentation by lon mutants of Escherichia coli K-12.

Authors:  S Gottesman; E Halpern; P Trisler
Journal:  J Bacteriol       Date:  1981-10       Impact factor: 3.490

10.  The mechanism of action of fosfomycin (phosphonomycin).

Authors:  F M Kahan; J S Kahan; P J Cassidy; H Kropp
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

View more
  9 in total

1.  Study of intra-inter species protein-protein interactions for potential drug targets identification and subsequent drug design for Escherichia coli O104:H4 C277-11.

Authors:  Shakhinur Islam Mondal; Zabed Mahmud; Montasir Elahi; Arzuba Akter; Nurnabi Azad Jewel; Md Muzahidul Islam; Sabiha Ferdous; Taisei Kikuchi
Journal:  In Silico Pharmacol       Date:  2017-04-11

2.  Structure of MurA (UDP-N-acetylglucosamine enolpyruvyl transferase) from Vibrio fischeri in complex with substrate UDP-N-acetylglucosamine and the drug fosfomycin.

Authors:  D C Bensen; S Rodriguez; J Nix; M L Cunningham; L W Tari
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-03-27

Review 3.  Fosfomycin.

Authors:  Matthew E Falagas; Evridiki K Vouloumanou; George Samonis; Konstantinos Z Vardakas
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

4.  Organoarsenicals inhibit bacterial peptidoglycan biosynthesis by targeting the essential enzyme MurA.

Authors:  Luis D Garbinski; Barry P Rosen; Masafumi Yoshinaga
Journal:  Chemosphere       Date:  2020-04-27       Impact factor: 7.086

5.  Comparative proteomic analysis of Streptococcus suis biofilms and planktonic cells that identified biofilm infection-related immunogenic proteins.

Authors:  Yang Wang; Li Yi; Zongfu Wu; Jing Shao; Guangjin Liu; Hongjie Fan; Wei Zhang; Chengping Lu
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

6.  Comparative genome analysis of non-toxigenic non-O1 versus toxigenic O1 Vibrio cholerae.

Authors:  Munmun Mukherjee; Prathusha Kakarla; Sanath Kumar; Esmeralda Gonzalez; Jared T Floyd; Madhuri Inupakutika; Amith Reddy Devireddy; Selena R Tirrell; Merissa Bruns; Guixin He; Ingrid E Lindquist; Anitha Sundararajan; Faye D Schilkey; Joann Mudge; Manuel F Varela
Journal:  Genom Discov       Date:  2014

7.  The Antibiotic Fosfomycin Mimics the Effects of the Intermediate Metabolites Phosphoenolpyruvate and Glyceraldehyde-3-Phosphate on the Stenotrophomonas maltophilia Transcriptome.

Authors:  Teresa Gil-Gil; Luz Edith Ochoa-Sánchez; José Luis Martínez
Journal:  Int J Mol Sci       Date:  2021-12-23       Impact factor: 5.923

8.  Transporter Genes and fosA Associated With Fosfomycin Resistance in Carbapenem-Resistant Klebsiella pneumoniae.

Authors:  Yu-Ping Wang; Yen-Hao Chen; I-Cheng Hung; Po-Hsun Chu; Yu-Han Chang; Yi-Tsung Lin; Hung-Chih Yang; Jin-Town Wang
Journal:  Front Microbiol       Date:  2022-01-31       Impact factor: 5.640

9.  In vitro efficacy of vancomycin combined with fosfomycin against Vancomycin-Resistant Enterococci strains.

Authors:  Gulseren Aktas
Journal:  Pak J Med Sci       Date:  2020 Jan-Feb       Impact factor: 1.088

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.